Rifabutin-Based Rescue Therapy for <i>Helicobacter pylori</i> Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients

Rifabutin-Based Rescue Therapy for <i>Helicobacter pylori</i> Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients

The most commonly used regimens fail to eradicate <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection in 5&#8315;10% of patients. Those not cured with treatments based on amoxicillin, clarithromycin, nitroimidazoles, fluoroquinolones, bismuth or tetracycline have no o...

Full description

Bibliographic Details
Main Authors: Davide Giuseppe Ribaldone, Sharmila Fagoonee, Marco Astegiano, Marilena Durazzo, Anna Morgando, Tatiana Sprujevnik, Chiara Giordanino, Monica Baronio, Claudio De Angelis, Giorgio Maria Saracco, Rinaldo Pellicano
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Journal of Clinical Medicine
Subjects:
rifabutin
<i>Helicobacter pylori</i>
gastritis
peptic ulcer
dyspepsia
gastric cancer
Online Access:https://www.mdpi.com/2077-0383/8/2/199

Internet

https://www.mdpi.com/2077-0383/8/2/199

Similar Items